Business StandardCenter·
RPG Life Sciences to invest ₹500 cr in manufacturing, API capabilities
Drug firm RPG Life Sciences is planning to deploy Rs 500 crore over the next 12 months to strengthen its manufacturing and API capabilities through strategic acquisitions. In an interview with PTI, RPG Life Sciences Managing Director Ashok Nair said the company has embarked on a significant expansion phase, backed by a committed capital infusion of Rs 700 crore. "Currently, the acquisitions we have made are to the tune of Rs 200 crore. We are evaluating opportunities that can strengthen our man…
Read at Business Standard →
